Over the past few years, the Food and Drug Administration has approved various new treatments for Alzhimer's disease, but are ...
which is currently under FDA review. Approval for a monthly IV dose of Leqembi is also being sought. The Alzheimer’s Drug Discovery Foundation (ADDF) also welcomed the approval, saying it would ...
New research on tadpoles shows that the FDA-approved drug donepezil induces a reversible torpor-like state in the animals.
A chemist a UAlbany and his son are looking to make a major breakthrough in the world of Alzheimer's prevention. They believe ...
The U.K. regulatory authority approved the Alzheimer's disease drug, Leqembi, last month. But the U.K. cost-effectiveness ...
USF’s Memory Disorders Clinic fielding requests from patients and their families hoping that Donanemab can slow progressive ...
They used a drug prediction algorithm to predict ... Their top candidate was DNP, which has been approved since 1996 to treat Alzheimer’s. “Interestingly, clinical overdoses of DNP in patients ...
What is the new drug recently approved by the FDA for Alzheimer’s disease? In July, the U.S. Food and Drug Administration (FDA) approved Kisunla (donanemab) for the treatment of people living ...
The study, published in JAMA, analyzed postmortem brain tissue from 15 individuals with Down syndrome aged 43 to 68 years ...
Researchers have found that an Alzheimer's drug, donepezil, can induce a safe and reversible ... laevis frogs into a hibernation-like torpor state using donepezil (DNP), a drug approved by the FDA to ...
A third COVID-19 vaccine will be available shortly as Novavax joins Pfizer/BioNTech and Moderna in targeting variants that ...
Britain’s drug regulator has authorized the Alzheimer’s drug Leqembi, saying that it’s the first medicine to show some impact ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results